A deeper look at the clinical evidence supporting NeuralCIM® (NeuroEPO), illustrative patient outcomes, the specialists who deliver the program, and how a cycle is structured and invested in.
Cuba's Alzheimer's program draws on decades of biotechnology and neurorehabilitation research. These summaries outline the scientific basis — not a guarantee of individual results.
Preclinical and clinical studies from Cuba's Center of Molecular Immunology describe low-sialic-acid erythropoietin (NeuroEPO) as a candidate neuroprotective agent, with reported effects on neuronal survival pathways and cerebral perfusion in Alzheimer's models.
Rodríguez JC et al. — Center of Molecular Immunology (CIM), Havana.
Structured, repeated cognitive training targeting memory, attention, and executive function is associated with measurable gains in daily-function scales when delivered intensively in a multidisciplinary setting.
CIREN clinical outcome reports; peer-reviewed neurorehabilitation literature.
Coordinated teams of neurologists, neuropsychologists, and therapists — rather than isolated single-discipline visits — are linked to better adherence and sustained functional gains in neurodegenerative care.
International consensus on neurorehabilitation program design.
Programs that formally educate and counsel caregivers report lower institutionalization rates and better home-management of behavioral symptoms across the disease trajectory.
Alzheimer's caregiver intervention literature.
Educational summary only. Treatment eligibility is determined by specialist review of each patient's records. Outcomes vary and are not guaranteed.
Composite cases reflecting typical patient profiles and reported experiences. Names and details have been changed to protect privacy.
"After the first cycle my husband started remembering small things again — our grandchildren's names, the route to the park. It gave us back moments we thought were gone."
M. Alvarez, 68
Mild Alzheimer's, MoCA 19
Improved daily-function scores after 4-week cycle
"The team didn't just treat my mother — they taught our family how to keep the gains at home. The caregiver sessions changed how we communicate with her."
R. Thompson, 72
Moderate Alzheimer's, MMSE 16
Stabilized cognition across two cycles
"I came in scared of what I was forgetting. I left with a plan, a routine, and doctors who actually called to check on me after I went home."
L. Fernández, 65
MCI (early-stage)
Slowed decline on follow-up neuropsychological testing
Composite illustrative cases based on typical patient profiles. Names and details have been changed to protect privacy. Individual results vary.
A coordinated multidisciplinary team — not a single doctor — designs and delivers each personalized Alzheimer's program.
Neurologist — Alzheimer's & cognitive disorders
Leads diagnostic staging and the individualized treatment plan, integrating neuroimaging and neuropsychological data for each patient.
Neuropsychologist
Designs and monitors the cognitive rehabilitation protocol, tracking objective gains across attention, memory, and executive function.
Occupational Therapist
Translates clinical gains into real-world independence — adapting daily routines and the home environment for sustained function.
Clinical Pharmacist
Coordinates symptomatic medication with the NeuralCIM® cycle, monitoring interactions and side effects throughout the program.
Speech-Language Therapist
Addresses language and communication difficulties, supporting expression and comprehension where indicated.
Multilingual Care Coordinator
Supports international families across records, travel, and remote follow-up — bridging the Cuban clinical team and the US physician.
Every plan is individualized after specialist review. These tiers describe the typical pathways families explore — final scope and cost are confirmed after records evaluation.
Records review · 48 hours
No charge
4 weeks on-site
Core program
6–8 weeks on-site
Intensive track
Pricing varies with clinical complexity, program length, and required services. A written estimate is provided after the free remote records review. NeuroCuba does not guarantee specific outcomes, and all treatment is subject to specialist approval.
Submit medical records for a free remote review, or speak with an international care coordinator about the Alzheimer's program.